Stanford Cardiovascular Institute

Calling all Stanford T32 Trainees! Join us on Wednesday, March 26th from 4-6pm for the CVI Early Career Happy Hour. This event is a collaboration of past, current, and prospective T32 trainees to network, socialize, and hear about trainee experiences apart of the T32 and beyond. Date: March 26th from 4-6pm Location: Lokey Stem Cell, G1161

The 9th annual Stanford Drug Discovery Symposium brings together biotech, pharma, academia, and investors for two days of dynamic discussions, groundbreaking science, and unique networking opportunities. With exciting talks, engaging fireside chats, dynamic panel discussions, and an interactive poster session, this year's program promises to spark new ideas and collaborations. Register to attend at Stanford University on April 28-29, 2025: tinyurl.com/sdds2025

Thank you for participating in our weekly Frontiers in Cardiovascular Science seminar. Next week we’re excited to have Dr. Janeta Zoldan, PhD?give her talk on “Crafting The Stem Cell Niches: Advancing Cardiovascular Tissue Engineering through Microenvironment Engineering." Join us Tuesday, March 25th?at 12pm PST to hear her talk and visit https://lnkd.in/g4qBJrUR to learn more.

Thank you for participating in our weekly Frontiers in Cardiovascular Science seminar. Next week we’re excited to have Dr. Andrew Marks, MD?give his talk on “Structural Insights Into Novel Treatments for Heart Failure Targeting Leaky Ryanodine Receptors." Join us Tuesday, March 11th?at 12pm PST to hear his talk and visit?https://lnkd.in/g4qBJrUR?to learn more.

Congratulations to the awardees of the 2025 AHA Career Development Award! Your hard work, dedication, and innovative contributions to cardiovascular research are truly inspiring. We look forward to seeing the continued impact of your work in shaping the future of cardiovascular health! Bernardo Bonilauri, Amit Manhas, Ph.D., SIYEON RHEE, Lichao Liu, Lu Ren, Wenshu Zeng.

We’d like to take a moment to thank our incredible sponsors for their contributions to our upcoming 9th Annual Stanford Drug Discovery Symposium! We are incredibly grateful for their partnership and support. Join them in making #SDDS2025 a forefront for drug research and email?[email protected]. Sponsorships must be confirmed by April 1, 2025. We’re looking forward to working with you! Alexandria Real Estate Equities, Inc., Medical Excellence Capital, LLC, Medable, Inc, Amgen, AbbVie, BioMarin Pharmaceutical Inc.,??BioRender, Cytokinetics, Gilead Sciences, Gooter-Jensen Foundation, Stanford Health Care, a16z Bio + Health,?Takeda,?Wilson Sonsini Goodrich & Rosati, WuXi AppTec,?ACROBiosystems, Alamar Biosciences, Inc.,?Ansa Biotechnologies, Inc.,?Biortus,?BridgeBio,?Collaborative Drug Discovery - CDD Vault, Curie.Bio,?Cytiva,?Greenstone Biosciences,?NUVISAN The Science CRO,?SPARK Finland,?SPARK Norway,?Stanford Research Park,?Vala Sciences,?Walden Catalyst Ventures

Thank you for participating in our weekly Frontiers in Cardiovascular Science seminar. Next week we’re excited to have Dr. Sushma Reddy, MD?give her talk on “Microvascular Dysfunction in Congenital Heart Disease." Join us Tuesday, March 11th?at 12pm PST to hear her talk and visit?https://lnkd.in/g4qBJrUR?to learn more.

Thank?you for participating in our weekly?Frontiers in Cardiovascular Science seminar. This week we’re excited to have?Dr. Richard Gumina, MD, PhD?give his talk on “Impact of Ectonucleotidases on Cardiovascular Disease”. Join us Tuesday, March 4th?at 12pm PST to hear his talk and visit?https://lnkd.in/g4qBJrUR?to learn more.

Join us at the 9th Annual Stanford Drug Discovery Symposium on April 28-29, for 2 exciting days of talks and discussions, including our poster session. #SDDS2025 offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations.?Register now at?https://lnkd.in/gvqKZBzG! ?

Join us tonight for the CVI Early Career Happy Hour to hear James Zou on his Virtual Lab of AI Scientists concept on collaborative AI scientist agents conducting in silico research meetings to tackle open-ended, experimentally validated R&D projects. [Stanford only]